Trinity Biotech (TRIB) Competitors

$1.83
+0.00 (+0.08%)
(As of 10:14 AM ET)

TRIB vs. BMRA, CDIO, OCX, MYMD, NAVB, ICCC, AWH, ABIO, VNRX, and GCTK

Should you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include Biomerica (BMRA), Cardio Diagnostics (CDIO), OncoCyte (OCX), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), ImmuCell (ICCC), Aspira Women's Health (AWH), ARCA biopharma (ABIO), VolitionRx (VNRX), and GlucoTrack (GCTK). These companies are all part of the "medical" sector.

Trinity Biotech vs.

Biomerica (NASDAQ:BMRA) and Trinity Biotech (NASDAQ:TRIB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Biomerica has a beta of -1.04, suggesting that its stock price is 204% less volatile than the S&P 500. Comparatively, Trinity Biotech has a beta of 1.21, suggesting that its stock price is 21% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomerica
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Trinity Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

In the previous week, Biomerica and Biomerica both had 1 articles in the media. Trinity Biotech's average media sentiment score of 0.67 beat Biomerica's score of 0.00 indicating that Biomerica is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biomerica
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Trinity Biotech
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Biomerica has higher earnings, but lower revenue than Trinity Biotech. Biomerica is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biomerica$5.34M2.27-$7.14M-$0.37-1.95
Trinity Biotech$56.83M0.25-$24.02M-$3.17-0.58

Trinity Biotech received 181 more outperform votes than Biomerica when rated by MarketBeat users. Likewise, 70.98% of users gave Trinity Biotech an outperform vote while only 67.82% of users gave Biomerica an outperform vote.

CompanyUnderperformOutperform
BiomericaOutperform Votes
137
67.82%
Underperform Votes
65
32.18%
Trinity BiotechOutperform Votes
318
70.98%
Underperform Votes
130
29.02%

Trinity Biotech has a net margin of -42.26% compared to Trinity Biotech's net margin of -117.46%. Biomerica's return on equity of 0.00% beat Trinity Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Biomerica-117.46% -64.00% -50.95%
Trinity Biotech -42.26%N/A -36.02%

22.3% of Biomerica shares are held by institutional investors. Comparatively, 79.0% of Trinity Biotech shares are held by institutional investors. 13.5% of Biomerica shares are held by insiders. Comparatively, 8.2% of Trinity Biotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Trinity Biotech beats Biomerica on 9 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRIB vs. The Competition

MetricTrinity BiotechDiagnostic substances IndustryMedical SectorNASDAQ Exchange
Market Cap$13.80M$2.54B$4.80B$7.40B
Dividend YieldN/A0.76%5.47%3.96%
P/E Ratio-0.5876.19168.3315.55
Price / Sales0.2577.242,436.5782.06
Price / CashN/A15.1945.6134.56
Price / Book-0.593.624.664.30
Net Income-$24.02M$30.88M$102.38M$213.66M
7 Day Performance1.09%1.10%0.38%1.33%
1 Month Performance-12.74%-5.62%-5.81%-4.10%
1 Year Performance-64.76%-30.68%9.95%7.91%

Trinity Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BMRA
Biomerica
0 of 5 stars
$0.74
-3.9%
N/A-58.3%$12.42M$5.34M-2.0062Gap Up
CDIO
Cardio Diagnostics
1.8717 of 5 stars
$1.03
+3.0%
N/A-71.6%$22.24M$20,000.000.007
OCX
OncoCyte
1.2417 of 5 stars
$2.75
+8.7%
$3.87
+40.6%
-54.5%$22.72M$1.50M0.0075Analyst Report
Gap Up
High Trading Volume
MYMD
MyMD Pharmaceuticals
0 of 5 stars
$2.10
-7.5%
N/A-95.0%$4.54MN/A-0.3910News Coverage
Positive News
Gap Down
NAVB
Navidea Biopharmaceuticals
0 of 5 stars
$0.04
flat
N/A-85.6%$4.00M$8,126.00-0.6711Analyst Report
ICCC
ImmuCell
0 of 5 stars
$5.05
-0.4%
N/A+0.6%$39.14M$17.47M-6.7374High Trading Volume
AWH
Aspira Women's Health
1.0595 of 5 stars
$3.45
+1.8%
$4.45
+29.0%
-37.1%$42.57M$9.15M-0.2985Gap Down
ABIO
ARCA biopharma
0 of 5 stars
$3.27
+2.8%
N/A+88.1%$47.42MN/A-8.844
VNRX
VolitionRx
0 of 5 stars
$0.62
-8.8%
$2.50
+303.2%
N/A$50.88M$770,000.00-1.22110Gap Down
GCTK
GlucoTrack
0 of 5 stars
$0.52
+23.5%
N/A+8.6%$14.04MN/A-1.426Gap Down
High Trading Volume

Related Companies and Tools

This page (NASDAQ:TRIB) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners